首页> 外国专利> THERAPEUTIC DRUG FOR TREATING AND PREVENTING OSTEOPOROSIS, CARDIOVASCULAR DISEASE AND CHEST CANCER

THERAPEUTIC DRUG FOR TREATING AND PREVENTING OSTEOPOROSIS, CARDIOVASCULAR DISEASE AND CHEST CANCER

机译:药物治疗和预防骨质疏松症,心血管疾病和胸腺癌

摘要

PROBLEM TO BE SOLVED: To obtain a therapeutic drug for treating and preventing osteoporosis, cardiovascular disease and chest cancer. SOLUTION: This drug is a therapeutic drug for treating and preventing osteoporosis, cardiovascular disease and chest cancer without giving influence in the action of warfarin or propranolol on human patients who receive therapy by warfarin or propranolol and contains a pharmaceutically effective amount of estrogen agonist. It is desirable that the estrogen agonist is rasofoxifene (-) cis,6-phenyl-5-[4-(2pyrrolidin-1-yl-ethoxy)phenyl]-5,6,7,8,- tetrahydronaphthalen-2-ol} or droloxifene.
机译:要解决的问题:获得用于治疗和预防骨质疏松症,心血管疾病和胸部癌的治疗药物。解决方案:该药物是用于治疗和预防骨质疏松症,心血管疾病和胸部癌的治疗药物,不会对接受华法林或普萘洛尔治疗的人类患者产生华法林或心得安的作用,并且含有药物有效量的雌激素激动剂。理想的是,雌激素激动剂是雷索昔芬(-)顺式,6-苯基-5- [4-(2-吡咯烷-1-基-乙氧基)苯基] -5,6,7,8,-四氢萘-2-醇}或屈洛昔芬。

著录项

  • 公开/公告号JP2001048805A

    专利类型

  • 公开/公告日2001-02-20

    原文格式PDF

  • 申请/专利权人 PFIZER PROD INC;

    申请/专利号JP20000222159

  • 发明设计人 LI JULIA YU;

    申请日2000-07-24

  • 分类号A61K45/00;A61K31/138;A61K31/40;A61P5/30;A61P9/02;A61P19/10;A61P35/00;

  • 国家 JP

  • 入库时间 2022-08-22 01:28:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号